Elevated IL-17 and TGF-β Serum Levels: A Positive Correlation between T-helper 17 Cell-Related Pro-Inflammatory Responses with Major Depressive Disorder
- PMID: 27303608
- PMCID: PMC4892318
- DOI: 10.15412/J.BCN.03070207
Elevated IL-17 and TGF-β Serum Levels: A Positive Correlation between T-helper 17 Cell-Related Pro-Inflammatory Responses with Major Depressive Disorder
Abstract
Introduction: Depression is a mental disorder that highly associated with immune system. Therefore, this study compares the serum concentrations of IL-21, IL-17, and transforming growth factor β (TGF-β) between patients with major depressive disorder and healthy controls.
Methods: Blood samples were collected from 41 patients with major depressive disorder and 40 healthy age-matched controls with no history of malignancies or autoimmune disorders. The subjects were interviewed face to face according to DSM-IV diagnostic criteria. Depression score was measured using completed Beck Depression Inventory in both groups. The serum concentrations of IL-21, IL-17, and TGF-β were assessed using ELISA.
Results: The mean score of Beck Depression score in the patient and control groups was 35.4±5.5 and 11.1±2.3. IL-17 serum concentrations in the patients and the control group were 10.03±0.6 and 7.6±0.6 pg/mL, respectively (P=0.0002). TGF-β level in the patients group was significantly higher than compare to the control group; 336.7±20.19 vs. 174.8±27.20 pg/mL, (P<0.0001). However, the level of IL-21 was not statistically different between the two groups 84.30±4.57 vs. 84.12±4.15 pg/mL (P>0.05).
Conclusion: Considering pro-inflammatory cytokines, current results support the association of inflammatory response and depressive disorder. So, it seems that pro-inflammatory factors profile can be used as indicator in following of depression progress and its treatment impacts.
Keywords: Inflammatory response; Interleukin-17; Major depressive disorder; Transforming growth factor-beta; interleukin-21.
Figures
References
-
- Connor T. J., Leonard B. E. ( 1998). Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sciences, 62( 7), 583– 606. - PubMed
-
- Dubas-Slemp H., Marmurowska-Michałowska H., Szuster-Ciesielska A., Kamińska T., Kandefer-Szerszeń M. ( 2002). The role of cytokines in depression. Psychiatria Polska, 37( 5), 787– 798. - PubMed
-
- Duvallet E., Semerano L., Assier E., Falgarone G., Boissier M. C. ( 2011). Interleukin-23: a key cytokine in inflammatory diseases. Annual Medicine, 43( 7), 503– 511. - PubMed
-
- Harrington L. E., Hatton R. D., Mangan P. R., Turner H., Murphy T. L., Murphy K. M., et al. ( 2005). Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunology, 6( 11), 1123– 1132. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources